February 7th, 2007
MammaPrint®: First In Vitro Diagnostic Multivariate Index Assay (IVDMIA) Cleared by the USFDA
A product of Agendia BV, MammaPrint® breast cancer diagnostic test is a gene expression profiling service to assess the risk of recurrence in breast cancer patients recently cleared by the USFDA.
A U.S. Regulatory milestone as the first In Vitro Diagnostic Multivariate Index Assay (IVDMIA) to acquire market clearance from the FDA.
According to Dr. Bernhard Sixt, […]
Recent Comments